Volunteers over the age of 18 who do not have severe concomitant diseases, who have not been infected with Covid-19 and have not been vaccinated in the last 6 months, are invited to participate in the study. Monetary compensation is provided for participation in the study
The OLLA-MED investigators Professors M.A. Plekhanova and M.V. Vershinina, acted as organizers of the symposium on latent tuberculosis problems within the XXXIII National Congress on Respiratory Diseases. The symposium was also attended by A.P. Tkachuk, Head of the Translational Biomedicine Laboratory of the N.F. Gamalei Research Institute, creator of the GamTBvac vaccine, the study of which continues in our center.
Permission was obtained from the Ministry of Health of the Russian Federation to conduct a study of the safety and effectiveness of the vaccine against Covid-19 infection by St. Petersburg Institute of Vaccines and Serums of the Federal Medical and Biological Agency of Russia. We are waiting for the opening of the center!
Successfully completed a visit of the center's selection to participate in the study of a new drug for chemotherapy of non-small cell non-small cell lung cancer
